In vitro and in vivo performance of supersaturable self-nanoemulsifying system of trans-resveratrol

Figures & data

Figure 1. Globule size analysis of S-SNEDDS formulation.

Figure 2. Apparent drug concentration–time profile of OPT LCT-SNEDDS and S-SNEDDS formulations.

Figure 3. X-ray powder diffraction peaks of pure drug, OPT-LCT-SNEDDS and S-SNEDDS.

Figure 4. Plasma drug level profiles of pure drug, OPT LCT-SNEDDS and S-SNEDDS formulations. Each point represents the mean of six replicates and each cross bar indicates 1 SEM. The data of two groups, that is, pure drug and OPT LCT-SNEDDS, have been reproduced with permission, from Singh and Pai (2014b).

Singh G, Pai RS. 2014b. Trans-resveratrol self nano-emulsifying drug delivery systems 336 (SNEDDS) with enhanced bioavailability potential: Optimization, pharmacokinetics and in situ single pass intestinal perfusion (SPIP) studies. Drug Deliv. doi:https://doi.org/10.3109/10717544.2014.885616.

 Google Scholar